Correction: Vancomycin Dosing and Monitoring

The Medical Letter on Drugs and Therapeutics

FROM
ISSUE

1310

April 20, 2009

View Complete Issue Table of Contents 2019

Correction: Vancomycin Dosing and Monitoring

Download PDF: US English

Show Related
Terms Hide Related
Terms

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2009 Apr 20;51(1310):32

Disclosures

Objective(s)

Select a term to see related articles 2009 Aminoglycosides April 20 April 6 correction endocarditis Hospital acquired pneumonia hospital-acquired pneumonia Issue 1309 Issue 1310 Linezolid Methicillin-resistant Staphylococcus aureus infections MRSA infections page 25 Page 32 Penicillins Red man syndrome Red-man syndrome Vancocin Volume 51 Zyvox Zyvoxam

Vancomycin Dosing and Monitoring (Med Lett Drugs Ther 2009; 51:25)

In the paragraph on dosing, the second-to-last sentence should have said that the new recommendations suggest considering use of an alternative antibiotic when the MIC for the infecting organism is ≥2 mg/L, not >2 mg/L.

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.